Pajjiż: Irlanda
Lingwa: Ingliż
Sors: HPRA (Health Products Regulatory Authority)
SODIUM CHLORIDE POTASSIUM CHLORIDE SODIUM CITRATE GLUCOSE ANHYDROUS
Sinclair IS Pharma Limited
SODIUM CHLORIDE POTASSIUM CHLORIDE SODIUM CITRATE GLUCOSE ANHYDROUS
Powder for Oral Solution
Product not subject to medical prescription
Withdrawn
2010-08-01
PART II SUMMARY OF PRODUCT CHARACTERISTICS 1 NAME OF THE MEDICINAL PRODUCT Rapolyte- Natural Powder for Oral Solution. 2 QUALITATIVE AND QUANTITATIVE COMPOSITION 3 PHARMACEUTICAL FORM Powder for oral solution. White free-flowing crystalline powder. 4 CLINICAL PARTICULARS 4.1 THERAPEUTIC INDICATIONS In the correction of fluid and electrolyte loss in the management of watery diarrhoea. 4.2 POSOLOGY AND METHOD OF ADMINISTRATION The basic unit of dosage is the content of a single sachet reconstituted in 200ml of freshly boiled and cooled water. The solution must not be boiled after reconstitution. The solution should not be administered to infants or young children except under direction of a physician. _Infants:_ The solution is substituted for the milk feed. _Severe Diarrhoea:_ On the first day the usual dose is 150ml of solution/kg body weight with no milk. On each successive day there is a reduction of 30ml/kg in the volume of solution used and an increment of 30ml in the volume of milk. _Mild Diarrhoea:_ Give 200ml of solution as required on both Day 1 and Day 2 of treatment. Thereafter give the solution as a 1:1 dilution with the milk feed. _Older Children and Adults:_ Drink 50-100ml of solution/kg body weight every 4-6 hours. 4.3 CONTRAINDICATIONS Not applicable. Each sachet contains: Sodium Chloride Ph. Eur. 0.35 g Potassium Chloride Ph. Eur. 0.30 g Sodium Citrate Ph. Eur. 0.60 g Glucose Anhydrous Ph. Eur. 4.00 g IRISH MEDICINES BOARD ________________________________________________________________________________________________________________________ _Date Printed 06/03/2008_ _CRN 2047664_ _page number: 1_ 4.4 SPECIAL WARNINGS AND PRECAUTIONS FOR USE 1. The solution should not be administered to infants or young children except under the direction of a physician after a diagnosis has bee Aqra d-dokument sħiħ